Novartis reports H1N1 vaccine data

Novartis AG (NYSE:NVS; SIX:NOVN) said data from a pilot trial in 100 healthy volunteers showed that Celtura induced hemagglutination-inhibition titers of at least 1:40 in 80% of subjects after one dos...